about
MR imaging features of high-grade gliomas in murine models: how they compare with human disease, reflect tumor biology, and play a role in preclinical trialsA Metabolomic Approach to Understanding the Metabolic Link between Obesity and DiabetesMagnetic resonance spectroscopy in metabolic and molecular imaging and diagnosis of cancerMetabolomics of ApcMin/+ mice genetically susceptible to intestinal cancerCompeting views on cancer.Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot studyDeciphering squamous cell carcinoma using multidimensional genomic approaches.The role of complement in tumor growthUnraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approachMetabolic tumor imaging using magnetic resonance spectroscopy.(1)H nuclear magnetic resonance-based extracellular metabolomic analysis of multidrug resistant Tca8113 oral squamous carcinoma cells.Isotope enhanced approaches in metabolomics.Oncoproteomics: current trends and future perspectives.Application of metabonomics in drug development.High-dimensional biology to comprehend hepatocellular carcinoma.Prospects for clinical cancer metabolomics using stable isotope tracers.Metabolomics-based methods for early disease diagnosticsCurrent opportunities and challenges of magnetic resonance spectroscopy, positron emission tomography, and mass spectrometry imaging for mapping cancer metabolism in vivo.Metabolomic Analysis of Liver Tissue from the VX2 Rabbit Model of Secondary Liver TumorsIn vivo solid-phase microextraction in metabolomics: opportunities for the direct investigation of biological systems.MRS and MRSI guidance in molecular medicine: targeting and monitoring of choline and glucose metabolism in cancer.Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry.Cancer metabolism: what we can learn from proteomic analysis by mass spectrometry.Oncometabolomics in cancer research.Extraction for metabolomics: access to the metabolome.Metabolomic studies of human gastric cancer: reviewThe metabolomics of airway diseases, including COPD, asthma and cystic fibrosis.Challenges of analyzing different classes of metabolites by a single analytical method.Coefficient of Variation, Signal-to-Noise Ratio, and Effects of Normalization in Validation of Biomarkers from NMR-based Metabonomics Studies.Energy deprivation by silibinin in colorectal cancer cells: a double-edged sword targeting both apoptotic and autophagic machineries.Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer.Silibinin feeding alters the metabolic profile in TRAMP prostatic tumors: 1H-NMRS-based metabolomics study.Cancer Metabolism and Tumor Heterogeneity: Imaging Perspectives Using MR Imaging and Spectroscopy.Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra.
P2860
Q26863563-620120A5-7798-4332-A685-FC83E4B83411Q28083355-C2A16516-0934-4066-9679-1288F1A75760Q33881902-77531273-C21D-4204-9342-F6EE9C5CCBAFQ33904600-642AC30D-30D0-4CB5-AD77-54C8F97F452FQ34060169-AF5908D6-41D9-4FA5-B755-CC124F60E502Q34115285-ACD26180-C275-41A1-93E5-7F6957D7AFAEQ34475613-25D14C47-8A6F-4681-9A8B-6E0863EEF1E9Q35231345-75EDEF2C-B05F-4EE5-9F12-FB32976E1581Q35312645-77F97BE2-F853-408B-A34C-26F9B4DAC9C9Q35746099-D17B4F69-B053-411C-B4B2-A0E18CCFA550Q35758072-0F88904B-D3B2-4620-A4D5-B169FFDA9838Q36581517-90DDAFB7-4EDF-4D2F-A357-471552495732Q36841889-D3CF0C98-A2BE-4A78-BE99-4186F6C3CF6BQ37074082-E1617BAB-AA8B-40A3-993E-35F304654A86Q37087376-D55AF81A-37F2-4520-BA37-98BDDF9572D4Q37201287-6905F727-4D29-40D2-96A9-FAAC086C9E29Q37266489-8DE80BF1-5CC2-4D63-ABB9-710FFB1AE5E9Q37644820-87C961BC-D811-47FB-B453-D5F9546C63D8Q37645012-5FE27CCF-20A7-49F2-A527-77D53D1D4842Q37879073-A3915A40-AFB6-4DC0-AEB8-42B9243CF6E3Q37906482-D376EB7C-52FE-42D8-99F3-EE7F879FC3F0Q38009236-4222A46D-AD8E-4078-B224-CF604FFF708CQ38060693-76F16458-947A-44EC-ABD5-A0BB5ACB6DB8Q38132912-760C74A8-5CB0-42F6-8844-F7459089CB59Q38187634-20BB08D5-D73D-4428-BF3C-DEC647458238Q38227841-B9A6F573-727D-4E46-A250-F35284B6E7F0Q38268820-E2B0556B-56C9-4F50-BBB4-B86A925C3CFDQ38298357-ECFB5926-18F9-4AEA-BD67-867A00407A59Q38425546-4E698878-A4A5-4884-9F0D-8440726E9F2AQ39187724-4D3470C0-F5FA-408D-BD78-DCD02E76468DQ41134662-57720B75-0EF3-4EC7-895F-DAF3554E4D67Q43131403-5EC5714F-67B1-4A99-9187-AC44B951AD7BQ47162047-C5F9E06D-3CBD-45CF-AECF-EDC59C75DE3EQ51598103-D48C24DB-5E0A-44DA-92D9-EC5BF2E81815
P2860
description
2007 nî lūn-bûn
@nan
2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Tumour metabolomics in animal models of human cancer.
@ast
Tumour metabolomics in animal models of human cancer.
@en
type
label
Tumour metabolomics in animal models of human cancer.
@ast
Tumour metabolomics in animal models of human cancer.
@en
prefLabel
Tumour metabolomics in animal models of human cancer.
@ast
Tumour metabolomics in animal models of human cancer.
@en
P356
P1476
Tumour metabolomics in animal models of human cancer.
@en
P2093
Julian L Griffin
Risto A Kauppinen
P304
P356
10.1021/PR060464H
P577
2007-02-01T00:00:00Z